Enanta Pharmaceuticals
ENTA
ENTA
154 hedge funds and large institutions have $856M invested in Enanta Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 55 increasing their positions, 59 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% less funds holding
Funds holding: 169 → 154 (-15)
39% less capital invested
Capital invested by funds: $1.4B → $856M (-$544M)
52% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 21
Holders
154
Holding in Top 10
4
Calls
$7.16M
Puts
$619K
Top Buyers
| 1 | +$18.5M | |
| 2 | +$7.45M | |
| 3 | +$7.01M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$6.53M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.11M |
Top Sellers
| 1 | -$26.5M | |
| 2 | -$14.1M | |
| 3 | -$8.54M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.84M |
| 5 |
Walleye Capital
New York
|
-$4.49M |